Substance P Activates Heart Stem Cells in the Right Atrium After Heart Attack
Substance P specifically activated cardiac progenitor cells in the right atrium after ischemia-reperfusion injury, doubling their migration through NK-1R signaling.
Quick Facts
What This Study Found
After ischemia/reperfusion injury in rats, Substance P (5 nmol/kg injection) had specific effects on the right atrium (RA):
SP promoted expression of c-Kit, GATA4, Oct4, Nanog, and Sox2 only in the RA, not in other heart chambers. These are markers of cardiac progenitor cells (CPCs) and stem cell pluripotency.
In ex vivo RA explant outgrowths, NK1R-expressing c-Kit+/Nkx2.5+/GATA4+ CPCs migrated approximately 2-fold more from SP-treated RA tissue compared to untreated I/R tissue.
SP treatment promoted CPC proliferation, migration, cardiosphere formation (3D cell clusters indicating stemness), and differentiation into cardiomyocytes.
All effects were blocked by the NK1R antagonist RP67580, confirming the SP/NK1R pathway is required. The SP/NK1R system acts as a key mediator of CPC expansion in the RA within 24 hours after ischemia/reperfusion.
This identifies the right atrium as a specific niche for SP-responsive cardiac stem cells.
Key Numbers
88 rats; SP 5nmol/kg; 2-fold CPC migration increase; Oct4/Nanog/Sox2/c-Kit/GATA4 up in RA only; NK1R antagonist blocked all effects
How They Did This
Animal study with 88 Sprague-Dawley rats in 4 groups (n=22 each): sham, I/R only, SP+I/R, and NK1R antagonist+SP+I/R. Left anterior descending artery occluded 40 minutes followed by 1 day reperfusion. SP or SP+RP67580 injected. Both atria, ventricles, and heart apex collected at 1 day. Gene expression, immunohistochemistry, and ex vivo explant outgrowth assays performed.
Why This Research Matters
Heart attacks kill heart muscle cells that cannot regenerate. Activating the heart's own progenitor cells could enable natural repair. This study shows Substance P specifically activates cardiac progenitor cells in the right atrium after injury. If this SP/NK1R pathway can be harnessed, it could enhance natural heart repair after heart attack.
The Bigger Picture
Heart attacks kill heart muscle that cannot regenerate. If the heart contains its own reservoir of stem cells in the right atrium, and Substance P can activate them, this opens a pathway for stimulating natural cardiac repair without transplanting external cells.
What This Study Doesn't Tell Us
Tested in rats, not humans. The 24-hour time point captures only the initial response; long-term cardiac repair was not assessed. Whether activated CPCs actually integrate into damaged myocardium and improve heart function was not tested. SP has many other effects (pain, inflammation, vasodilation) that could complicate therapeutic use. The right atrium specificity may not translate to humans.
Questions This Raises
- ?Can SP-activated progenitor cells actually become functional heart muscle?
- ?Would NK-1R agonists improve outcomes after human heart attacks?
- ?Why is the right atrium a stem cell reservoir but not other chambers?
Trust & Context
- Key Stat:
- 2× migration of cardiac progenitor cells from the right atrium after Substance P injection following heart attack
- Evidence Grade:
- Moderate evidence from a well-designed animal study with 88 rats and appropriate controls including NK-1R antagonist.
- Study Age:
- Published in 2020. Cardiac progenitor cell biology remains an active but debated research area.
- Original Title:
- Substance P enhances the local activation of NK1R-expressing c-kit+ cardiac progenitor cells in right atrium of ischemia/reperfusion-injured heart.
- Published In:
- BMC molecular and cell biology, 21(1), 41 (2020)
- Authors:
- Jeong, Yun-Mi, Cheng, Xian Wu(2), Lee, Kyung Hye, Lee, Sora, Cho, Haneul, Kim, Weon
- Database ID:
- RPEP-04883
Evidence Hierarchy
Frequently Asked Questions
Does the heart have its own stem cells?
This study suggests the right atrium contains progenitor cells that can be activated by Substance P. These cells express stem cell markers and can migrate, potentially contributing to heart repair.
Could this help people who have had heart attacks?
Potentially. If Substance P can activate the heart's own repair cells, it could supplement or replace external stem cell transplantation. But this is early animal research — human application requires extensive further study.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-04883APA
Jeong, Yun-Mi; Cheng, Xian Wu; Lee, Kyung Hye; Lee, Sora; Cho, Haneul; Kim, Weon. (2020). Substance P enhances the local activation of NK1R-expressing c-kit+ cardiac progenitor cells in right atrium of ischemia/reperfusion-injured heart.. BMC molecular and cell biology, 21(1), 41. https://doi.org/10.1186/s12860-020-00286-x
MLA
Jeong, Yun-Mi, et al. "Substance P enhances the local activation of NK1R-expressing c-kit+ cardiac progenitor cells in right atrium of ischemia/reperfusion-injured heart.." BMC molecular and cell biology, 2020. https://doi.org/10.1186/s12860-020-00286-x
RethinkPeptides
RethinkPeptides Research Database. "Substance P enhances the local activation of NK1R-expressing..." RPEP-04883. Retrieved from https://rethinkpeptides.com/research/jeong-2020-substance-p-enhances-the
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.